<html xmlns:mso="urn:schemas-microsoft-com:office:office" xmlns:msdt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title></title>
<style type="text/css">
<!--
.Insert {  color: #339933; text-decoration: underline}
.Remove {  color: #FF0000; text-decoration: line-through}
-->
</style>

<!--[if gte mso 9]><xml>
<mso:CustomDocumentProperties>
<mso:BillNumber msdt:dt="string">646</mso:BillNumber>
<mso:BillSubject msdt:dt="string">Drug Paraphernalia</mso:BillSubject>
<mso:BillFiledDate msdt:dt="string">2025-11-21T08:53:00Z</mso:BillFiledDate>
<mso:BillShortTitle msdt:dt="string">Revising the definition of âdrug paraphernaliaâ to exclude certain narcotic-drug-testing products, etc.</mso:BillShortTitle>
<mso:BillVersionName msdt:dt="string">Original Filed Version</mso:BillVersionName>
<mso:BillLegislativeSessionName msdt:dt="string">2026</mso:BillLegislativeSessionName>
<mso:BillChamber msdt:dt="string">S</mso:BillChamber>
<mso:BillEffectiveDate msdt:dt="string">2026-07-01T00:00:00Z</mso:BillEffectiveDate>
<mso:BillTypeAbbreviation msdt:dt="string">GB</mso:BillTypeAbbreviation>
<mso:BillTypeName msdt:dt="string">General Bill</mso:BillTypeName>
<mso:BillVersion msdt:dt="string">__</mso:BillVersion>
</mso:CustomDocumentProperties>
</xml><![endif]-->
</head>
<body>
<pre style="line-height: 1.5em; font-size: 12px">
       <b>Florida Senate</b> - <b>2026</b>                                     <b>SB 646</b><b></b>
       <b></b>
       
        
       <b>By </b>Senator Gaetz
       
       
       
       
       
       1-00876-26                                             2026646__
    1                        A bill to be entitled                      
    2         An act relating to drug paraphernalia; providing
    3         legislative findings and intent; amending s. 893.145,
    4         F.S.; revising the definition of âdrug paraphernaliaâ
    5         to exclude certain narcotic-drug-testing products;
    6         providing an effective date.
    7          
    8  Be It Enacted by the Legislature of the State of Florida:
    9  
   10         Section 1.â<u class="Insert">(1)</u><u class="Insert">â</u><u class="Insert">The Legislature finds and declares that</u>
   11  <u class="Insert">this state continues to experience unprecedented deaths caused</u>
   12  <u class="Insert">by synthetic opioids, stimulants, and other adulterated or</u>
   13  <u class="Insert">misrepresented substances in the illicit drug supply.</u>
   14         <u class="Insert">(2)</u><u class="Insert">â</u><u class="Insert">In the 2024 Annual Report of the Florida Medical</u>
   15  <u class="Insert">Examiners, Florida Department of Law Enforcement, the most</u>
   16  <u class="Insert">frequently occurring drugs found in decedents were fentanyl and</u>
   17  <u class="Insert">fentanyl analogs, benzodiazepines, cannabinoids, morphine,</u>
   18  <u class="Insert">xylazine, cocaine, methamphetamine, amphetamine, gabapentin,</u>
   19  <u class="Insert">cathinones, and oxycodone.</u>
   20         <u class="Insert">(3)</u><u class="Insert">â</u><u class="Insert">The Legislature recognizes that drug-testing products,</u>
   21  <u class="Insert">including test strips, reagent kits, and related products, are</u>
   22  <u class="Insert">evidence-based harm reduction strategies that do not encourage</u>
   23  <u class="Insert">drug use, but, instead, prevent overdose and death by allowing</u>
   24  <u class="Insert">individuals and communities to identify the presence of</u>
   25  <u class="Insert">dangerous controlled substances and adulterants.</u>
   26         <u class="Insert">(4)</u><u class="Insert">â</u><u class="Insert">It is the intent of the Legislature to decriminalize</u>
   27  <u class="Insert">the possession, distribution, and use of drug-testing products</u>
   28  <u class="Insert">so that residents of this state can access life-saving</u>
   29  <u class="Insert">information about controlled substances and adulterants before</u>
   30  <u class="Insert">tragedy occurs.</u>
   31         Section 2.âSection 893.145, Florida Statutes, is amended to
   32  read:
   33         893.145ââDrug paraphernaliaâ defined.âThe term âdrug
   34  paraphernaliaâ means all equipment, products, and materials of
   35  any kind which are used, intended for use, or designed for use
   36  in planting, propagating, cultivating, growing, harvesting,
   37  manufacturing, compounding, converting, producing, processing,
   38  preparing, <s class="Remove">testing,</s> analyzing, packaging, repackaging, storing,
   39  containing, concealing, transporting, injecting, ingesting,
   40  inhaling, or otherwise introducing into the human body a
   41  controlled substance in violation of this chapter or s. 877.111.
   42  Drug paraphernalia is deemed to be contraband which shall be
   43  subject to civil forfeiture. The term includes, but is not
   44  limited to:
   45         (1)âKits used, intended for use, or designed for use in the
   46  planting, propagating, cultivating, growing, or harvesting of
   47  any species of plant which is a controlled substance or from
   48  which a controlled substance can be derived.
   49         (2)âKits used, intended for use, or designed for use in
   50  manufacturing, compounding, converting, producing, processing,
   51  or preparing controlled substances.
   52         (3)âIsomerization devices used, intended for use, or
   53  designed for use in increasing the potency of any species of
   54  plant which is a controlled substance.
   55         (4)âTesting equipment used, intended for use, or designed
   56  for use in identifying, or in analyzing the strength,
   57  effectiveness, or purity of, controlled substances<u class="Insert">. The term</u>
   58  <u class="Insert">does not include test strips, reagent kits, or any other</u><s class="Remove">,</s>
   59  <s class="Remove">excluding</s> narcotic-drug-testing products that are used solely to
   60  determine whether a controlled substance contains fentanyl as
   61  described in s. 893.03(2)(b)9. or <u class="Insert">dangerous fentanyl or fentanyl</u>
   62  <u class="Insert">analogues as</u> <s class="Remove">any other controlled substance</s> specified in s.
   63  893.135(1)(c)4.a.<u class="Insert">, xylazine, cocaine, amphetamines, cathinones,</u>
   64  <u class="Insert">or any other controlled substance or adulterant.</u> This exclusion
   65  does not apply to a narcotic-drug-testing product that can
   66  measure or determine the quantity, weight, or potency of a
   67  controlled substance.
   68         (5)âScales and balances used, intended for use, or designed
   69  for use in weighing or measuring controlled substances.
   70         (6)âDiluents and adulterants, such as quinine
   71  hydrochloride, caffeine, dimethyl sulfone, mannitol, mannite,
   72  dextrose, and lactose, used, intended for use, or designed for
   73  use in diluting controlled substances; or substances such as
   74  damiana leaf, marshmallow leaf, and mullein leaf, used, intended
   75  for use, or designed for use as carrier mediums of controlled
   76  substances.
   77         (7)âSeparation gins and sifters used, intended for use, or
   78  designed for use in removing twigs and seeds from, or in
   79  otherwise cleaning or refining, cannabis.
   80         (8)âBlenders, bowls, containers, spoons, and mixing devices
   81  used, intended for use, or designed for use in compounding
   82  controlled substances.
   83         (9)âCapsules, balloons, envelopes, and other containers
   84  used, intended for use, or designed for use in packaging small
   85  quantities of controlled substances.
   86         (10)âContainers and other objects used, intended for use,
   87  or designed for use in storing, concealing, or transporting
   88  controlled substances.
   89         (11)âHypodermic syringes, needles, and other objects used,
   90  intended for use, or designed for use in parenterally injecting
   91  controlled substances into the human body.
   92         (12)âObjects used, intended for use, or designed for use in
   93  ingesting, inhaling, or otherwise introducing controlled
   94  substances, as described in s. 893.03, or substances described
   95  in s. 877.111(1) into the human body, such as:
   96         (a)âMetal, wooden, acrylic, glass, stone, plastic, or
   97  ceramic pipes, with or without screens, permanent screens,
   98  hashish heads, or punctured metal bowls.
   99         (b)âWater pipes.
  100         (c)âCarburetion tubes and devices.
  101         (d)âSmoking and carburetion masks.
  102         (e)âRoach clips: meaning objects used to hold burning
  103  material, such as a cannabis cigarette, that has become too
  104  small or too short to be held in the hand.
  105         (f)âMiniature cocaine spoons, and cocaine vials.
  106         (g)âChamber pipes.
  107         (h)âCarburetor pipes.
  108         (i)âElectric pipes.
  109         (j)âAir-driven pipes.
  110         (k)âChillums.
  111         (l)âBongs.
  112         (m)âIce pipes or chillers.
  113         (n)âA cartridge or canister, which means a small metal
  114  device used to contain nitrous oxide.
  115         (o)âA charger, sometimes referred to as a âcracker,â which
  116  means a small metal or plastic device that contains an interior
  117  pin that may be used to expel nitrous oxide from a cartridge or
  118  container.
  119         (p)âA charging bottle, which means a device that may be
  120  used to expel nitrous oxide from a cartridge or canister.
  121         (q)âA whip-it, which means a device that may be used to
  122  expel nitrous oxide.
  123         (r)âA tank.
  124         (s)âA balloon.
  125         (t)âA hose or tube.
  126         (u)âA 2-liter-type soda bottle.
  127         (v)âDuct tape.
  128         Section 3.âThis act shall take effect July 1, 2026.

</pre>
</body>
</html>
